CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
9.72
1.32%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Thu: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 9.85
Open* 9.91
1-Year Change* 67.4%
Day's Range* 9.71 - 10.08
52 wk Range 4.89-22.69
Average Volume (10 days) 605.24K
Average Volume (3 months) 15.32M
Market Cap 331.96M
P/E Ratio -100.00K
Shares Outstanding 57.73M
Revenue 9.64M
EPS -1.91
Dividend (Yield %) N/A
Beta 1.82
Next Earnings Date Mar 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 9.72 -0.17 -1.72% 9.89 10.15 9.61
Mar 27, 2024 9.85 0.76 8.36% 9.09 9.86 9.09
Mar 26, 2024 9.11 -0.65 -6.66% 9.76 9.88 9.07
Mar 25, 2024 9.72 0.18 1.89% 9.54 10.08 9.54
Mar 22, 2024 9.44 -0.65 -6.44% 10.09 10.18 9.42
Mar 21, 2024 10.22 -0.93 -8.34% 11.15 12.25 10.00
Mar 20, 2024 11.02 0.58 5.56% 10.44 11.44 10.44
Mar 19, 2024 10.79 -0.01 -0.09% 10.80 11.10 10.24
Mar 18, 2024 11.34 -0.03 -0.26% 11.37 11.49 10.25
Mar 15, 2024 10.71 0.83 8.40% 9.88 11.26 9.69
Mar 14, 2024 10.00 -0.16 -1.57% 10.16 10.75 9.34
Mar 13, 2024 9.81 0.22 2.29% 9.59 10.00 9.47
Mar 12, 2024 9.57 0.14 1.48% 9.43 9.77 9.31
Mar 11, 2024 9.36 -0.68 -6.77% 10.04 10.28 9.32
Mar 8, 2024 10.17 -0.05 -0.49% 10.22 11.29 9.96
Mar 7, 2024 10.20 0.02 0.20% 10.18 10.77 10.08
Mar 6, 2024 10.49 0.59 5.96% 9.90 11.12 9.88
Mar 5, 2024 9.98 -0.41 -3.95% 10.39 10.79 9.78
Mar 4, 2024 10.86 -0.16 -1.45% 11.02 11.34 10.34
Mar 1, 2024 11.07 -0.15 -1.34% 11.22 11.36 10.58

Nano-X Imaging Ltd. Events

Time (UTC) Country Event
Monday, April 1, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2023 Nano-X Imaging Ltd Earnings Call
Q4 2023 Nano-X Imaging Ltd Earnings Call

Forecast

-

Previous

-

Time (UTC)

12:30

Country

US

Event

Q4 2023 Nano-X Imaging Ltd Earnings Release
Q4 2023 Nano-X Imaging Ltd Earnings Release

Forecast

-

Previous

-
Monday, May 20, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Nano-X Imaging Ltd Earnings Release
Q1 2024 Nano-X Imaging Ltd Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 8.578 1.304 0 0 0
Total Operating Expense 126.288 62.862 43.923 22.571 1.904
Selling/General/Admin. Expenses, Total 36.492 37.266 34.713 19.854 1.232
Research & Development 26.507 17.122 9.21 2.717 0.672
Operating Income -117.71 -61.558 -43.923 -22.571 -1.904
Other, Net 0.108 0.008 -0.005
Net Income Before Taxes -116.921 -61.846 -43.815 -22.563 -1.909
Net Income After Taxes -113.243 -61.798 -43.815 -22.563 -1.909
Net Income Before Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
Net Income -113.243 -61.798 -43.815 -22.563 -1.909
Income Available to Common Excl. Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
Income Available to Common Incl. Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
Diluted Net Income -113.243 -61.798 -43.815 -22.563 -1.909
Diluted Weighted Average Shares 52.235 48.216 35.654 44.3939 44.3939
Diluted EPS Excluding Extraordinary Items -2.16795 -1.28169 -1.22889 -0.50825 -0.043
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.42338 -1.22135 -1.22889 -0.50825 -0.043
Revenue 8.578 1.304
Cost of Revenue, Total 15.458 2.816
Gross Profit -6.88 -1.512
Unusual Expense (Income) 59.663 4.476
Other Operating Expenses, Total -12.185 1.182
Interest Income (Expense), Net Non-Operating 0.789 -0.288
Depreciation / Amortization 0.353
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 2.582 2.447 2.132 2.438 2.2
Total Operating Expense 20.413 14.525 55.888 22.267 24.383
Selling/General/Admin. Expenses, Total 6.183 6.628 6.119 8.589 10.065
Research & Development 6.913 6.286 7.095 6.089 6.493
Unusual Expense (Income) 2.181 2.236 40.1 3.595 3.773
Operating Income -17.831 -12.078 -53.756 -19.829 -22.183
Other, Net
Net Income Before Taxes -17.451 -11.855 -53.869 -19.524 -21.712
Net Income After Taxes -17.364 -11.761 -52.837 -19.126 -19.614
Net Income Before Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
Net Income -17.364 -11.761 -52.837 -19.126 -19.614
Income Available to Common Excl. Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
Income Available to Common Incl. Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
Diluted Net Income -17.364 -11.761 -52.837 -19.126 -19.614
Diluted Weighted Average Shares 55.375 55.157 52.4 52.276 52.192
Diluted EPS Excluding Extraordinary Items -0.31357 -0.21323 -1.00834 -0.36587 -0.3758
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.28797 -0.18688 -0.51092 -0.32117 -0.32882
Revenue 2.582 2.447 2.132 2.438 2.2
Cost of Revenue, Total 4.273 3.97 3.879 3.897 3.955
Gross Profit -1.691 -1.523 -1.747 -1.459 -1.755
Other Operating Expenses, Total 0.766 -4.692 -1.305 0 0
Interest Income (Expense), Net Non-Operating 0.38 0.223 -0.113 0.305 0.471
Depreciation / Amortization 0.097 0.097 0.097 0.097
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 82.461 94.857 219.793 9.636 1.699
Cash and Short Term Investments 77.624 88.711 213.468 8.072 0.005
Cash & Equivalents 38.463 66.645 213.468 8.072 0.005
Prepaid Expenses 2.414 3.129 6.325 1.564 1.694
Total Assets 253.933 363.17 236.149 11.871 1.855
Property/Plant/Equipment, Total - Net 44.702 39.16 15.379 0.754 0.156
Property/Plant/Equipment, Total - Gross 46.365 40.028 15.723 0.89 0.239
Accumulated Depreciation, Total -1.663 -0.868 -0.344 -0.136 -0.083
Other Long Term Assets, Total 2.933 1.184 0.977 1.481 0
Total Current Liabilities 25.074 52.751 4.48 20.263 8.239
Accounts Payable 3.619 3.134 0.435 0.475 0.082
Accrued Expenses 12.98 4.492 4.045 1.968 0
Notes Payable/Short Term Debt 0 0.145 0 0 0
Other Current Liabilities, Total 8.475 44.98 17.82 8.157
Total Liabilities 37.253 71.022 5.403 20.649 8.239
Total Long Term Debt 3.481 3.796 0 0 0
Other Liabilities, Total 5.368 7.412 0.923 0.386 0
Total Equity 216.68 292.148 230.746 -8.778 -6.384
Common Stock 0.158 0.149 0.131 0.075 0.058
Additional Paid-In Capital 477.953 438.82 315.031 31.748 11.596
Retained Earnings (Accumulated Deficit) -259.457 -146.214 -84.416 -40.601 -18.038
Total Liabilities & Shareholders’ Equity 253.933 363.17 236.149 11.871 1.855
Total Common Shares Outstanding 55.0942 51.7914 46.1002 44.3939 44.3939
Short Term Investments 39.161 22.066
Total Receivables, Net 0.977 1.051
Accounts Receivable - Trade, Net 0.977 1.051
Other Current Assets, Total 1.446 1.966
Goodwill, Net 7.42 58.298
Intangibles, Net 91.219 101.826
Long Term Investments 25.198 67.845
Long Term Debt 3.481 3.796
Deferred Income Tax 3.33 7.063
Other Equity, Total -1.974 -0.607
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total Current Assets 77.519 81.855 82.461 90.61 89.766
Cash and Short Term Investments 74.464 78.091 77.624 88.037 86.634
Cash & Equivalents 41.998 37.571 38.463 40.331 51.676
Prepaid Expenses 0.901 1.501 2.414 0.103 0.804
Total Assets 224.885 238.965 253.933 305.686 317.724
Property/Plant/Equipment, Total - Net 46.453 46.588 44.702 45.367 44.456
Other Long Term Assets, Total 1.76 1.718 2.933 2.858 2.954
Total Current Liabilities 23.433 24.167 25.074 43.592 40.612
Accounts Payable 3.967 3.716 3.619 5.588 1.858
Accrued Expenses 13.205 12.903 12.98 2.909 3.801
Notes Payable/Short Term Debt 0 0 0 0.145 0.145
Total Liabilities 31.35 32.235 37.253 57.854 55.448
Total Long Term Debt 3.428 3.451 3.481 3.481 3.481
Other Liabilities, Total 1.347 1.381 5.368 6.443 6.588
Total Equity 193.535 206.73 216.68 247.832 262.276
Common Stock 0.159 0.158 0.158 0.15 0.15
Additional Paid-In Capital 482.971 479.172 477.953 456.761 451.825
Retained Earnings (Accumulated Deficit) -288.582 -271.218 -259.457 -206.62 -187.494
Total Liabilities & Shareholders’ Equity 224.885 238.965 253.933 305.686 317.724
Total Common Shares Outstanding 55.5598 55.1503 55.0942 52.2665 52.2147
Short Term Investments 32.466 40.52 39.161 47.706 34.958
Long Term Investments 5.82 12.818 25.198 29.023 40.067
Other Equity, Total -1.013 -1.382 -1.974 -2.459 -2.205
Long Term Debt 3.428 3.451 3.481 3.481 3.481
Total Receivables, Net 1.431 1.308 0.977 1.121 1.203
Accounts Receivable - Trade, Net 1.431 1.308 0.977 1.121 1.203
Other Current Assets, Total 0.723 0.955 1.446 1.349 1.125
Goodwill, Net 7.42 7.42 7.42 43.96 43.96
Intangibles, Net 85.913 88.566 91.219 93.868 96.521
Other Current Liabilities, Total 6.261 7.548 8.475 34.95 34.808
Deferred Income Tax 3.142 3.236 3.33 4.338 4.767
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -113.243 -61.798 -43.815 -22.563 -1.909
Cash From Operating Activities -43.385 -38.071 -21.487 -5.524 -3.671
Cash From Operating Activities 0.905 0.524 0.208 0.053 0.035
Non-Cash Items 71.024 18.804 24.781 16.245 0.115
Changes in Working Capital -8.945 2.747 -2.661 0.741 -1.912
Cash From Investing Activities 14.606 -116.32 -13.937 -0.125 -0.073
Capital Expenditures -7.171 -23.158 -13.937 -0.125 -0.073
Cash From Financing Activities 0.804 7.379 240.991 13.861 3.684
Financing Cash Flow Items -0.145 0 -0.339 0
Issuance (Retirement) of Stock, Net 0.949 3.583 240.991 14.2 3.684
Net Change in Cash -28.243 -147.012 205.567 8.212 -0.06
Amortization 10.607 1.768
Deferred Taxes -3.733 -0.116
Other Investing Cash Flow Items, Total 21.777 -93.162
Issuance (Retirement) of Debt, Net 0 3.796
Cash Taxes Paid 0.147
Cash Interest Paid 0.09
Foreign Exchange Effects -0.268
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -11.761 -113.243 -60.406 -41.28 -21.666
Cash From Operating Activities -10.674 -43.385 -30.507 -22.284 -10.955
Cash From Operating Activities 0.255 0.905 0.626 0.404 0.206
Amortization 2.653 10.607 7.958 5.305 2.653
Deferred Taxes -0.094 -3.733 -2.725 -2.296 -0.178
Non-Cash Items 1.671 71.024 29.927 25.415 6.946
Changes in Working Capital -3.398 -8.945 -5.887 -9.832 1.084
Cash From Investing Activities 9.616 14.606 3.501 -6.77 -1.12
Capital Expenditures -1.495 -7.171 -7.387 -5.76 -3.815
Other Investing Cash Flow Items, Total 11.111 21.777 10.888 -1.01 2.695
Cash From Financing Activities 0.176 0.804 0.63 14.082 0.387
Financing Cash Flow Items -0.145 13.557
Issuance (Retirement) of Stock, Net 0.176 0.949 0.63 0.525 0.387
Issuance (Retirement) of Debt, Net 0 0
Net Change in Cash -0.893 -28.243 -26.376 -14.972 -11.724
Cash Taxes Paid 0 0.116
Cash Interest Paid 0.04 0.017
Foreign Exchange Effects -0.011 -0.268 -0.036

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Nano-X Imaging Ltd. Company profile

Nano-X Imaging Ltd. (NNOX) is a medical imaging technology company that develops, manufactures and commercialises digital X-ray source technology based on a novel digital micro-electromechanical systems (MEMS) semiconductor cathode.   

Founded in 2011 and headquartered in Neve Ilan, Israel, Nano-X Imaging leverages disruptive technology to transform and aid the medical industry.

The company aims to reduce the cost of medical imaging systems. Its imaging products are designed to transmit all imaging data to the cloud Software as a Service (SaaS) platform, which would employ a matching engine to match scans to radiologists. 

Nano-X’s proprietary technologies include Nanox.ARC, Nanox.CLOUD and Nanox.TUBE. 

Nanox.ARC is a medical imaging system that incorporates the novel digital X-ray source, while the Nanox.CLOUD is a companion cloud-based software that allows the delivery of medical screening as a service.

The Nanox.CART X-Ray System has received United States Food and Drug Administration (FDA) clearance using the Nanox.SOURCE. 

The company also provides Nanox.CLOUD Services, which is a medical AI system that would provide first response and decision assistive information. 

Nano-X Imaging went public on the NASDAQ under the ticker symbol ‘NNOX’ in August 2020.

Industry: Medical Imaging Systems

Communications Center
NEVE 'ILAN
9085000
IL

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.62 Price
-2.650% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,540.34 Price
-0.930% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

69,992.70 Price
-1.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading